New collaboration to boost inherited disease research

June 8, 2016

Professor Prasit Watanapa (left) with Professor David MorrisonMurdoch University has launched a partnership with an institution in Thailand which will enhance its groundbreaking research into treatments for inherited diseases.

An agreement between Mahidol University in Bangkok, Thailand, and Murdoch University and its partners, the Western Australian Neuroscience Research Institute (WANRI) will result in joint PhD projects which investigate molecular medicine treatments for inherited disorders.

The agreement with Mahidol, signed on Friday, May 20, will see one or more PhD candidates spend at least one year at Murdoch and two in Bangkok, researching in Mahidol’s Faculty of Medicine, Siriraj Hospital.

The first students will be co-supervised by Murdoch researchers Professors Steve Wilton, Sue Fletcher and Norman Palmer from the Centre of Comparative Genomics, Murdoch University and WANRI.

Murdoch University Deputy Vice Chancellor Research and Innovation Professor David Morrison said the partnership would give the PhD candidates the opportunity to experience international study.

“The agreement also facilitates and enhances academic and research cooperation and collaboration between Murdoch and Mahidol,” he added.

“The partnership reflects Murdoch University’s core research philosophy, which includes a focus on Health Futures and translating research findings into solutions for real world problems.”

WANRI Chief Executive Officer Steve Arnott also applauded the collaboration agreement.

“This association further enhances the relationship with both Murdoch and Mahidol Universities with whom WANRI has existing affiliation and collaborative arrangements and provides an excellent opportunity for top quality PhD students,” he said.

The Mahidol University delegation was led by Professor Prasit Watanapa, Dean of the Faculty of Medicine, Siriraj Hospital.

Print This Post Print This Post

Leave a comment

You can use these tags : <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

We read every comment and will make every effort to approve each new comment within one working day. To ensure speedy posting, please keep your comments relevant to the topic of discussion, free of inappropriate language and in-line with the editorial integrity of this newsroom. If not, your comments may not be published.

Thanks for commenting!